by Sue Robbins | Mar 9, 2020 | Migraine
The Food and Drug Administration (FDA) has approved Nurtec™ ODT (rimegepant; Biohaven) for the acute treatment of migraine with or without aura in adults. Nurtec ODT is a calcitonin gene-related peptide receptor antagonist administered via an orally disintegrating...
by Sue Robbins | Mar 9, 2020 | Miscellaneous
Aspirin, the original wonder drug, has long been a go-to medicine for millions, a Jack-of-all trades remedy that is readily available and cheap. Championed for its ability to relieve pain, fever and inflammation, aspirin has been a staple in home medicine cabinets and...
by Sue Robbins | Mar 9, 2020 | Migraine
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Qtrypta™ (M207) (zolmitriptan intracutaneous microneedle system; Zosano Pharma) for the acute treatment of migraine. Qtrypta delivers zolmitriptan, a selective...
by Sue Robbins | Mar 5, 2020 | Migraine
If you have raging headaches and you spend a lot of time on your smartphone, a new study suggests you might want to put your phone down whenever you can. Researchers found that folks who use their smartphones frequently and have headaches or migraines also tend to...
by Sue Robbins | Mar 2, 2020 | Miscellaneous
The FDA has approved Voltaren Arthritis Pain for nonprescription, over-the-counter use, according to a press release. Voltaren (diclofenac sodium topical gel 1%, GlaxoSmithKline), a NSAID previously available only with a prescription, is intended for the temporary...
